Wednesday, January 11, 2012

Dose for extended release Levofloxacin ocular

Dose for extended release Levofloxacin ocular

Levofloxacin is a fluoroquinolone antibacterial drug effective in the treatment of bacterial conjunctivitis and other ocular infections. Levofoxacin eye drop is available in the market for the treatment of anti bacterials
12.One drop of levofloxacin eye drop
= 0.05ml (approximately)

Quantity of drug instilled at one time (1-2
drops/time) = 250-500 µg

Quantity of drug instilled in one day (6-12
drops/ day) = 1500-3000 µg

The quantity of levofloxacin in the ocular insert can be between 1.5-3.0 mg for one day treatment using eye drops. Thus, 2.25 mg of levofloxacin is taken as the minimum required quantity for one day treatment. It was presumed that there would be a negligible loss of drug through ocular inserts when the drug is released at a constant rate over a period of 24hrs.
Assumption was also made that the ocular inserts will produce a better clinical response than the eye drops.
Posted by at


Bioelectronic DNA detection involves forming an electronic circuit mediated by nucleic acid hybridization and it serves as the basis for a DNA detection system called eSensor™ [1-4]. This system uses low-density DNA chips containing electrodes coated with DNA capture probes. Target DNA present in the sample hybridizes specifically both to capture probes and ferrocene labeled signal probes in solution thereby generating an electric current. Currente Sensor DNA chips contain as many as 36 electrodes for simultaneous detection of multiple pathogens from a single sample.

Many pathogens cause both acute and chronic disease at relatively low copy number and may be difficult or impossible to propagate in culture. Thus, most pathogen detection systems rely on nucleic acid amplification by using polymerase chain reaction (PCR). One highly effective amplification strategy targets conserved sequences among the family of organisms of interest. Such broad-range PCR strategies have been used to identify and characterize several known and previously uncharacterized bacteria [5,6] and viruses [7,8]. In order to maximize the utility of these effective pathogen nucleic acid amplification systems, amplification needs to be coupled with rapid, sensitive, and specific detection. Bioelectronic DNA detection by use of the eSensor chip might fulfill this need.

Human papillomaviruses (HPV) serve as an ideal model system for determining the efficiency and feasibility of eSensor DNA detection technology since there are at least 30 distinct genital HPV types that can be effectively amplified with broad-range consensus PCR primers. We designed two eSensor chips, each containing 14 probes specific for the conserved L1 region of the HPV genome. We evaluated clinical cervical cytology samples known to contain one or more HPV types. The eSensor DNA detection platform successfully detected the correct HPV type in most of these clinical samples, demonstrating that the system provides a rapid, sensitive, specific, and economical approach for multiple-pathogen detection and identification from a single sample.Background We used human papillomaviruses (HPV) as a model system to evaluate the utility of a nucleic acid, hybridization-based bioelectronic DNA detection platform (eSensor) in identifying multiple pathogens.